Find a Cancer Program  Log in to MyNetwork
Facebook  LinkedIn  Twitter  ACCC Youtube Channel

Search Drug Alphabetically

Generic Name Bicalutamide
Brand Name Casodex®
Payment Category Medicare Part D
Year Introduced 1995
Type of Drug Androgen inhibitor

FDA-Approved Indication(s)

  • Indicated for use in combination with a luteinizing hormone-releasing hormone analog for the treatment of Stage D2 metastatic carcinoma of the prostate. 150 mg daily not approved for use alone or with other agents. (2/27/15)

Approved Indication(s) with Orphan Drug Status None
ICD-10 Code(s) for Labeled Indication(s) Malignant neoplasm of prostate [C61]
Name Strength Form Package Labeler NDC

Copyright © 2021 Association of Community Cancer Centers. All Rights Reserved.
11600 Nebel Street, Suite 201, Rockville, MD 20852  |  Tel.: 301.984.9496  |  Fax: 301.770.1949